Cardiovascular News |
|
|
|
11/19/2009
Vitamin B Niacin Offers No Extra Benefit To Statin Therapy In Seniors Already Diagnosed With CAD
The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial n...
Source: Johns Hopkins Medical Institutions |
11/19/2009
Drug For Erectile Dysfunction Improves Heart Function In Young Heart-Disease Patients
Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to...
Source: Children's Hospital of Philadelphia |
11/19/2009
AstraZeneca PLC (AZN) Asks For U.S. Approval Of Brilinta
AstraZeneca (NYSE: AZN - News) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatme...
Source: PRNewswire |
11/19/2009
Sleep Apnea May Cause Heart Disease In Kidney Transplant Patients
Sleep apnea is common in individuals who receive a kidney transplant and is associated with increased risk of high blood pressure, heart disease or stroke, according to a study appearing in an upcomin...
Source: American Society of Nephrology |
11/18/2009
AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA?), an Investigational Antiplatelet Agent
AstraZeneca today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reducti...
Source: AstraZeneca |
11/18/2009
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient® for Patients with Acute Coronary Syndromes Managed with PCI
PARSIPPANY, N.J. and INDIANAPOLIS, Nov. 18 /PRNewswire-FirstCall/ --Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one fo...
Source: Eli Lilly and Company |
11/18/2009
Egyptian Mummies Reveal Heart Disease as Ancient Affliction
A new study finds that atherosclerosis, hardening of the arteries, was common in ancient Egyptians, challenging a belief that vascular disease is a modern affliction caused by current-day risk factors...
Source: University of California - San Diego |
11/18/2009
Increased Obesity Hindering Success At Reducing Heart Disease Risk
The dramatic increase in overweight and obesity in adult Americans over the past 20 years has undermined public health success at reducing risk for heart disease, according to research presented at th...
Source: American Heart Association |
11/18/2009
Motivational “women-Only” Cardiac Rehab Improves Symptoms Of Depression
Depressive symptoms improved among women with coronary heart disease who participated in a motivationally-enhanced cardiac rehabilitation program exclusively for women, according to research presented...
Source: American Heart Association |
11/18/2009
Some Obese People Perceive Body Size As OK, Dismiss Need To Lose Weight
Some obese people misperceive that their body size is normal and think they don’t need to lose weight, according to research presented at the American Heart Association’s Scientific Sessions 2009....
Source: American Heart Association |
11/18/2009
Prevalence Of High LDL, Or 'bad' Cholesterol Levels Decreases In US
Between 1999 and 2006, the prevalence of adults in the U.S. with high levels of LDL cholesterol, the "bad" cholesterol, decreased by about one-third, according to a study in the November 18 issue of J...
Source: JAMA and Archives Journals |
11/18/2009
Heart Failure Patients With Kidney Dysfunction Don't Recover Well After Hospital Discharge
Most heart failure patients who develop kidney failure in the hospital do not recover from it before going home and are at increased risk of either being re-hospitalized or dying within the year, acco...
Source: Henry Ford Health System |
11/18/2009
Drug Therapy More Cost-Effective Than Angioplasty For Diabetic Patients With Heart Disease
STANFORD, Calif. — Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford Univ...
Source: Stanford University Medical Center |
11/18/2009
Family Partnership, Education Interventions Lower Heart Failure Patients' Salt Consumption
Educating family members of heart failure (HF) patients about the health benefits of consuming a low-salt diet and providing skills for support and communication can effectively reduce HF patients' so...
Source: Emory University |
11/18/2009
Newer Heart Devices Significantly Improve Survival, Complication Rate And Quality Of Life
A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate permanent therapy f...
Source: University of Louisville Health Sciences Center |
11/18/2009
Inhibition Of GRK2 Is Protective Against Acute Cardiac Stress Injuries
(PHILADELPHIA) Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to tw...
Source: Thomas Jefferson University |
11/18/2009
Your Own Stem Cells Can Treat Heart Disease
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in le...
Source: Northwestern University |
11/18/2009
Secondhand Smoke Exposure Worse For Toddlers, Obese Children
Toddlers and obese children suffer more than other youth when exposed to secondhand smoke, according to research presented at the American Heart Association’s Scientific Sessions 2009....
Source: American Heart Association |
11/17/2009
American College of Cardiology/American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel and Omeprazole
Today the FDA notified healthcare professionals of new safety information concerning a drug interaction between clopidogrel, an anti-clotting medication, and omeprazole, a proton pump inhibitor (PPI)...
Source: American Heart Association; American College of Cardiology |
 |
| Next Page |
|
